← Back to Search

Behavioral Intervention

SBIRT for Alcohol and Substance Use Disorders

N/A

Waitlist Available

Led By Kelli S Hall, MD

Research Sponsored by Columbia University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up during the 12-month sustainment phase

Awards & highlights

Study Summary

This trial tests if providing SBIRT in an SRH setting impacts alcohol/substance use, SRH, mental & physical health, & quality of life.

Who is the study for?

This trial is for adults over 18 in the U.S. with internet access who show risky alcohol or substance use behaviors based on standardized screening. It's focused on patients at sexual and reproductive health clinics, aiming to improve various aspects of their health and wellbeing.Check my eligibility

What is being tested?

The trial tests SBIRT (Screening, Brief Intervention, Referral to Treatment) effectiveness in-person or via telemedicine compared to usual care. It examines impacts on substance use, sexual/reproductive health, mental/physical health, quality of life across different demographics.See study design

What are the potential side effects?

Since SBIRT involves non-medical interventions like counseling and referrals rather than drugs or medical procedures, it typically doesn't have physical side effects but may involve emotional discomfort during discussions about personal issues.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ during the 12-month sustainment phase

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~during the 12-month sustainment phase

This trial's timeline: 3 weeks for screening, Varies for treatment, and during the 12-month sustainment phase for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Average drinks per drinking day (T0)

Average drinks per drinking day (T1)

Average drinks per drinking day (T2)

+19 more

Secondary outcome measures

AUDIT-C score (T0)

AUDIT-C score (T1)

AUDIT-C score (T2)

+55 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: SBIRTExperimental Treatment1 Intervention

Screening, Brief Intervention, and Referral to Treatment (SBIRT) is an evidence-based approach supported by national healthcare organizations, including the Preventative Services Task Force and the American College of Obstetrics and Gynecologists. Validated tools (AUDIT-C and NIDA ASSIST) will efficiently screen an individual's substance use risk. Patients who screen in the risky/harmful range then receive a brief motivational interviewing-based intervention adapted from the evidence-based Brief Negotiated Interview, lasting 5-10 minutes, which provides feedback, helps explore health risks, and motivates change. Individuals who screen in the severe category, indicating a likely AUD/SUD, also receive a brief intervention, aimed at increasing motivation to accept a referral to treatment, and requiring a more intensive approach will also receive a warm-hand off referral to specialty addiction treatment.

Group II: Usual CareActive Control1 Intervention

None of the clinic sites have implemented standardized screening, brief intervention, or referral to treatment components. In this setting, usual care consists of basic quantity and frequency questions asked inconsistently as part of the admission process and varying by provider, with no standardized approach to screening, treatment, follow-up, or referral.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor

1,431 Previous Clinical Trials

2,460,233 Total Patients Enrolled

National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH

800 Previous Clinical Trials

1,362,411 Total Patients Enrolled

Planned Parenthood League of MassachusettsOTHER

18 Previous Clinical Trials

14,447 Total Patients Enrolled

Media Library

SBIRT (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05910580 — N/A

Alcohol Use Disorder Research Study Groups: SBIRT, Usual Care

Alcohol Use Disorder Clinical Trial 2023: SBIRT Highlights & Side Effects. Trial Name: NCT05910580 — N/A

SBIRT (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05910580 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many medical facilities have been enlisted to facilitate this experiment?

"Currently, there are 4 medical centers actively recruiting for this trial: Metro West Health Center in Marlborough, Western Massachusetts Health Center in Springfield, Central Massachusetts Health Center in Worcester and another quartet of sites."

Answered by AI

Are there any vacancies in this medical experiment for volunteers?

"As per clinicaltrials.gov, this trial is not currently enrolling participants, having first been posted on June 1st of 2023 and last updated the week after. However, there are 618 other trials actively in search of volunteers presently."

Answered by AI

What is the core intent of this medical experiment?

"This clinical trial's primary objective, measured during the Baseline period, is to assess Average drinks per drinking day (T1). Secondary outcomes comprise of AUDIT-C score (T1) and AUDIT-C score (T2), which are used to identify hazardous drinkers or those with active alcohol use disorders. Additionally, Anxiety Score (T0) will be evaluated using the Generalized Anxiety Disorder 7-item scale for anxiety severity over a two week period; scores between 0 - 4 represent minimal anxiety while scores from 15 - 21 indicate severe levels of distress."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years

Kelli S. Hall 2024. "Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05910580.

All > Substance Abuse